CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Insulin detemir

Last Updated: December 19, 2005
Result type: Reports
Project Number: S0049
Product Line: Common Drug Review

Generic Name: Insulin detemir

Brand Name: Levemir

Manufacturer: Novo Nordisk Canada Inc.

Indications: Diabetes mellitus

Submission Type: New

Project Status: Complete

Date Recommendation Issued: August 2, 2006

Recommendation Type: Do not list